---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-032160"
form_type: "8-K"
ticker: "RNXT"
cik: "0001574094"
company_name: "RenovoRx, Inc."
filed_at: "2023-09-11T23:59:59+00:00"
generated_at: "2026-06-10T21:41:35.627199+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# RenovoRx amends bylaws for universal proxy rules; appoints Dr. Spiegel to Compensation Committee

## Summary
- Board reduced stockholder meeting quorum from majority to one-third of voting power.
- Enhanced disclosure requirements for stockholder nominations and proposals, aligning with Rule 14a-19.
- Modified adjournment procedures and list of stockholders per DGCL amendments.
- Dr. Robert Spiegel appointed to Compensation Committee; full committee rosters disclosed.

## SEC filing metadata
- accession: 0001493152-23-032160
- form_type: 8-K
- ticker: RNXT
- cik: 0001574094
- company_name: RenovoRx, Inc.
- filed_at: 2023-09-11T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1574094/000149315223032160/0001493152-23-032160-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1574094/000149315223032160/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-032160
- JSON: https://secwatch.observer/filing/0001493152-23-032160.json
- Plain text: https://secwatch.observer/filing/0001493152-23-032160.txt

## Key facts
- Governance Changes
  RenovoRx, Inc.: Reduced stockholder meeting quorum requirement from a majority to one-third of voting power and enhanced procedural mechanics for stockholder nominations and proposals, including Universal Proxy Rule compliance (effective 2023-09-07).
  - Change: bylaw amendment
  - Effective: 2023-09-07
  source text: On September 7, 2023, in connection with the adoption of Rule 14a-19 (the “Universal Proxy Rules”) under the Securities Exchange Act of 1934, as amended, certain recent changes to the Delaware General Corporation Law (the “DGCL”), and a periodic review of the bylaws of RenovoRx, Inc. (the “Company”), the Board of Directors of the Company (the “Board”) adopted amended and restated bylaws (the “Amended and Restated Bylaws”), effective immediately
  evidence_url: https://www.sec.gov/Archives/edgar/data/1574094/000149315223032160/0001493152-23-032160-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.